OptimizeRx Corp — Director's Dealing 2010

Apr 26, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2010-04-19

Reporting Person: Harrell David (Director, Chairman of the Board)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-04-19	Common Stock	J	300000	—	Acquired	3836250	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-04-26	Stock Options	$1.81	J	200000	Acquired	2015-04-26	Common Stock (200000)	Direct

Footnotes

F1: Mr. Harrell received common stock of the Issuer in lieu of technocial contributions.